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The diagnosis of invasive pneumococcal disease (IPD) is currently based on culture methods,
which lack sensitivity, especially after antibiotic therapy. Molecular methods have improved
sensitivity and do not require viable bacteria; however, their use is complicated by reports of low
specificity with some assays. The present study investigated the specificity of a real-time PCR
targeting lytA for the detection of IPD. A group of 147 healthy children, aged 6 months to 16 years
(mean 6.4 years, median 4.9 years, interquartile range 6.4 years), who were in hospital for routine
examinations, were tested for pneumococcal carrier status and for the presence of detectable
pneumococcal DNA in their blood by real-time PCR targeting the pneumococcal lytA gene. In
addition, 35 culture-positive biological samples were analysed. Urine was examined for the
presence of pneumococcal DNA and C-polysaccharide antigen. Carriage was detected in 77 of
the 147 subjects (52.4%); however, regardless of carrier status, none of the subjects had a
positive result from blood. Analysis of the culture-positive biological samples yielded positive
results in 100% (15/15) of cerebrospinal fluid samples and 95% (19/20) of blood samples. All
urine samples from healthy carriers were negative for DNA, whilst antigenuria was detected in 44/
77 carriers (57.1%). In conclusion, real-time PCR is both sensitive and specific and can be a
useful tool in the routine diagnosis of IPD. Its sensitivity, which surpasses that of other methods for
this purpose, does not come at the cost of reduced specificity.
INTRODUCTION
Streptococcus pneumoniae is the leading cause of invasive
bacterial infections in children. Worldwide, an estimated
10.6 million children below the age of 5 years present with
pneumococcal disease every year. Other at-risk populations
include the elderly and immunosuppressed. Overall, more
than 1.6 million deaths per year are attributable to such
infections (Black et al., 2003; WHO, 2007). Establishing a
microbiological diagnosis is important for proper treat-
ment and epidemiological analysis.
Culture has been considered the gold standard for diag-
nosing invasive pneumococcal disease (IPD). However,
this method suffers from a lack of sensitivity, especially
when used after antibiotic therapy has been started to treat
the infection (Azzari et al., 2010; Resti et al., 2009) or when
small volumes are available, as is common in paediatric
practice (Isaacman et al., 1996). An immunochromato-
graphic method to detect bacterial cell-wall C polysacchar-
ide antigen excreted in urine is sensitive but does not
appear to distinguish between colonization and invasive
disease. Potentially, these obstacles could be overcome by
the use of quantitative PCR.
Recently, it has been demonstrated that molecular methods
for detecting bacterial DNA in blood or other normally
sterile body fluids can be used for the efficient diagnosis
and serotyping of IPD (Antonio et al., 2009; Azzari et al.,
2008, 2010; Blaschke et al., 2010; Carvalho et al., 2010;
Chiba et al., 2009; Corless et al., 2001; Saha et al., 2008;
Strachan et al., 2011; Van Gastel et al., 2007). These
methods do not require viable bacteria, need only small
sample volumes and appear to be more sensitive than
culture methods, making them potentially useful tools for
the diagnosis and serotyping of pneumococcal pneumonia
(Resti et al., 2010), even in conjunction with antibiotic
treatment (Resti et al., 2009). A large number of clinical
diagnostic laboratories around the world now use molecu-
lar methods as part of their routine testing. However,
whenever a test appears to be more sensitive than those
previously considered as gold standards, it is important to
determine whether this increase in sensitivity is accom-
panied by a reduction in specificity and hence an increase
in the rate of false-positives. For example, tests performedAbbreviations: Ct, threshold cycle; IPD, invasive pneumococcal disease.
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in the past using end-point PCR and primers targeting part
of the streptococcal pneumolysin (ply) gene sequence
reported finding positive results in the blood of healthy
subjects even in the absence of S. pneumoniae colonization
(Dagan et al., 1998; Murdoch et al., 2003).
The aim of the present study was to determine the
frequency of positive PCR results in the blood of healthy
carriers and non-carriers (i.e. false-positives) when assayed
with a sensitive real-time PCR employing reagents to detect
the pneumococcal autolysin (lytA) gene sequence, which is
reported to be more specific than other genes such as ply
(Abdeldaim et al., 2010; Carvalho et al., 2007).
METHODS
Subjects. The study included 147 healthy children between the ages
of 6 months and 16 years (median 4.9 years, interquartile range 6.4
years), who were present at the Anna Meyer Children’s Hospital,
Florence, Italy, for routine examinations related to allergies or coeliac
disease. None of the healthy subjects had taken antibiotics or received
anti-pneumococcal vaccination for at least 1 month prior to the
examination. Culture-positive biological samples of blood (20
samples) and cerebrospinal fluid (15 samples) were also tested.
Moreover, real-time PCR was performed on 15 urine samples from
patients with invasive pneumococcal infection (meningitis or
pneumonia) whose blood samples were positive by real-time PCR.
PCR conditions. The presence of S. pneumoniae DNA in blood, urine
or nasal swabs was evaluated by real-time PCR as described previously
(Azzari et al., 2010). Primers and probes within the previously
published lytA gene sequence (Carvalho et al., 2007) were used in PCR
amplifications at a final concentration of 400 nM for the primers and
400 nM for the probe, which was labelled with 6-carboxy-49,
59-dichloro-29,79-dimethoxyfluorescein (JOE). A negative control (no
template) and a positive control were included in every PCR run. Total
DNA was extracted from 200 ml blood or urine using a QIAmp DNeasy
Blood & Tissue kit (Qiagen), according to the manufacturer’s
instructions. Nasal swabs were placed in 1 ml PBS and mixed by
vortexing for 1 min, and DNA was extracted from a 200 ml sample.
Real-time PCR was performed with an ABI 7000 sequence detection
system (Applied Biosystems) using the following cycling parameters:
95 uC for 10 min, followed by 45 cycles of 95 uC for 15 s and 60 uC for
1 min. Cycle threshold (Ct) values were used to identify amplification
of the target sequence and to estimate bacterial load. Samples were
assumed to be negative if no increase in fluorescence signal was
observed after 45 cycles. All reactions were performed in triplicate.
For quantitative analysis of carriage density, the amount of bacterial
DNA was obtained by direct extrapolation of the Ct values to the
amount of DNA (in copies ml21) as read from the concentration
versus Ct standard curve, as described previously (Rello et al., 2009;
Resti et al., 2010).
S. pneumoniae bacterial cell-wall antigens were detected using a C
polysaccharide antigen NOW Urinary Antigen Assay (Binax)
according to the manufacturer’s instructions.
Power of the study. Very few data are available on PCR positivity
for S. pneumoniae in the blood of healthy children (Dagan et al., 1998;
Murdoch et al., 2003).
A rate of false positivity in the diagnosis of invasive pneumococcal
infection below 0.7 % was considered acceptable in the clinical setting,
being one-quarter of the false-positive samples obtained with culture
methods, which, in a paediatric setting, appears to be around 2.8 %
(Sard et al., 2006). For that reason, as we hypothesized that we would
not find a single positive with our method, the study was designed to
include at least 142 healthy children, in the hope of finding at least one
positive result that would allow quantification of the false-positive rate.
For comparison of our method (real-time PCR of lytA) with previous
reports evaluating the presence of pneumococcal DNA in healthy
children (nested end-point PCR of ply), assuming a carriage rate of 50 %
for the paediatric population studied, a sample size of only 80 subjects
would be sufficient to detect a statistically significant difference.
RESULTS AND DISCUSSION
The low sensitivity of methods that require culture for the
detection of pneumococcal disease may be due in part to
their sensitivity to antibiotic therapy. PCR is a more
sensitive assay (Antonio et al., 2009; Azzari et al., 2008,
2010; Corless et al., 2001; Saha et al., 2008; Van Gastel
et al., 2007); however, the question of its specificity has
been raised by the reported findings of positive PCR results
from the blood of healthy subjects (Dagan et al., 1998;
Murdoch et al., 2003). Both of these studies used sequences
from the pneumococcal ply gene as the target for PCR.
Recently, the specificity of the ply gene as a target for PCR-
based detection of IPD has been questioned (Abdeldaim
et al., 2009; Neeleman et al., 2004). When ply is used for
diagnosis of pneumococcal infection on bronchoalveolar
lavage or sputum samples, the presence in such samples of
other bacteria such as Streptococcus mitis or Streptococcus
oralis can be the cause of false-positive results, as these
bacteria are known to contain similar sequences (Abdeldaim
et al., 2009). However, it is difficult to imagine that a similar
mechanism might be the cause of positivity for ply sequences
in the blood of healthy subjects, and technical issues should
also be considered. In fact, the studies that found positivity
for ply sequences in the blood of healthy subjects used a
nested end-point PCR, which is known to give a higher rate
of false-positive results because it requires greater manip-
ulation of the samples and amplicons. Recently, the lytA
gene sequence has been suggested as more specific for the
diagnosis of pneumococcal disease (Abdeldaim et al., 2010;
Carvalho et al., 2007) and real-time PCR appears to be a
more sensitive and specific tool for microbiological analysis.
Therefore, we undertook the present study to determine the
false-positive rate using real-time PCR with the pneumo-
coccal lytA gene as the target.
We cannot exclude the possibility that carriage densities in the
previous studies were higher than in our patients, thus
affecting the passage of bacteria to the blood. However, the
results of our study seem to contradict this hypothesis; in fact,
the carriage density in the 77 carrier children in our study was
in some subjects very high: values ranged between 1.6 and 5.2
log copies ml21, with a mean value of 2.4 log copies ml21 and
an interquartile range of 2.2–3.7 log copies ml21.
Carrier status
In total, 77 of the 147 subjects (52.4 %) were positive
for pneumococcal colonization of the pharynx using our
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real-time PCR method on nasal swabs. This is consistent
with the expected 50 % carriage rate for this population
that we used in our power calculation. The age distribution
of carrier status is presented in Fig. 1. There were few
carriers among children under the age of 1 year and among
children over the age of 13 years. This reflects the typical
pattern of low carriage rates for very young children,
followed by increasing rates that peak between 1 and 2
years of age and then decline, rates being much lower in
adults (Antonio et al., 2009; Azzari & Resti, 2008; Leino et
al., 2001; Regev-Yochay et al., 2004).
Pneumococcal DNA in blood
Regardless of carrier status, we did not find positive results
with PCR in the blood of any of the 147 subjects tested.
The incidence of false-positive results appeared, therefore,
to be equal to zero or at least less than 1/147 (,0.7 %) for
children under the age of 16 years. PCR analysis of the
culture-positive biological samples yielded positive results
in 100 % (15/15) of cerebrospinal fluid samples and 95 %
(19/20) of blood samples, with an overall sensitivity of
97 % (34/35). This is in agreement with our findings in a
large population of children with pneumonia (Resti et al.,
2010), where among the 292 patients who were tested with
both culture and real-time PCR methods, S. pneumoniae
was detected by one of the two methods in 47 patients, 45
of whom (96 %) were positive by real-time PCR with a
sensitivity of real-time PCR that was four times higher than
that of culture (Resti et al., 2010).
Antigenuria
We found that, despite having negative PCR results for
pneumococcal DNA in the blood, 44 of the 77 carriers
(57.1 %) had positive results for antigen in the urine, whilst
the 70 non-carriers were all negative. This finding is
consistent with previous reports of positive tests in a large
percentage of children (Charkaluk et al., 2006; Domı´nguez
et al., 2003; Dowell et al., 2001). In an attempt to under-
stand this phenomenon, we examined urine samples for
the presence of bacterial DNA and found none, indicating
that colonization of the urinary tract was unlikely. We
examined whether a correlation existed between the
bacterial load colonizing the pharynx, as estimated by
quantitative real-time PCR, and positivity for antigen in
the urine, but did not find a significant correlation
(P50.41). Moreover, there was no strong correlation
between antigen in the urine and age (P50.09).
The absence of pneumococcal DNA in the blood and urine
argues against disseminated infection as the source of
antigen. We speculate that the antigenuria results from
ingestion of colonized nasal secretions, followed by
absorption of C-polysaccharide antigen from the digestive
tract and excretion by the kidneys. Our findings serve to
underline that, whilst useful for testing in adults where
the carriage rate is low (Smith et al., 2009), tests for
C-polysaccharide antigen in urine are not useful in
children because a positive result can be due to either
colonization or IPD. With regard to the presence of
pneumococcal DNA in the urine of IPD patients, we
demonstrated that only 2/15 blood-positive IPD patients
(13.3 %) also had positive urine samples. PCR performed
on urine samples thus seems less sensitive than PCR or
cultures performed on blood in patients with IPD. Larger
studies designed to compare PCR sensitivity in different
biological fluids are needed to confirm this point.
Real-time PCR assays of normally sterile body fluids, on
the other hand, are specific for invasive disease in children
and are more sensitive than culture methods. Using highly
sensitive real-time PCR avoids the use of nested PCR
Fig. 1. S. pneumoniae carrier status according
to age, as determined by real-time PCR
analysis of nasal swabs.
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assays, which are associated with lower specificity (Avni et
al., 2010) and present more possibilities for introducing
method-based false-positives from contamination.
One limitation of the present study was that it was only
performed on children with intact immune responses. Future
studies will need to investigate the other two major at-risk
populations – adults over the age of 65 and immunosup-
pressed subjects (Black et al., 2003) – to determine whether
the method is also applicable to these populations.
In conclusion, real-time PCR detecting the lytA gene
sequence is both sensitive and specific and can be a useful
tool in the routine diagnosis of IPD. Its sensitivity, which
surpasses that of any other method for this purpose, does
not come at the cost of reduced specificity.
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